BGCP
LLY icon

Bristol Gate Capital Partners’s Eli Lilly LLY Stock Holding History

Bristol Gate Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.8M Sell
62,345
-13,267
-18% -$13.6M 5.21% 3
2026
Q1 		$69.5M Sell
75,612
-4,966
-6% -$5.03M 4.48% 10
2025
Q4 		$86.6M Sell
80,578
-13,262
-14% -$12.7M 5% 2
2025
Q3 		$71.6M Sell
93,840
-3,023
-3% -$2.25M 4.23% 15
2025
Q2 		$75.5M Sell
96,863
-21,412
-18% -$16.6M 4.29% 14
2025
Q1 		$97.7M Buy
+118,275
New +$98.4M 4.77% 8

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bristol Gate Capital Partners's LLY Position: Q2 2026 in Review

Bristol Gate Capital Partners reduced its Eli Lilly (LLY) stake by 18% in Q2 2026, selling an estimated $13.6M and leaving 62,345 shares worth $74.8M. The position accounts for 5.21% of the portfolio, ranked #3.

Bristol Gate Capital Partners first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $97.7M in Q1 2025. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bristol Gate Capital Partners held 62,345 shares of Eli Lilly worth $74.8M as of Q2 2026.
  • Bristol Gate Capital Partners sold 13,267 Eli Lilly shares in Q2 2026, an estimated $13.6M.
  • Eli Lilly made up 5.21% of Bristol Gate Capital Partners's portfolio in Q2 2026, its #3 holding.
  • Bristol Gate Capital Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • Bristol Gate Capital Partners's Eli Lilly position peaked at $97.7M in Q1 2025.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bristol Gate Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.